Recent Finacing
Recent Raise
Angstrom Bio develops sequencing-based molecular diagnostics using barcode-based library prep plus bioinformatics to error-correct Oxford Nanopore reads, offering SARS-CoV-2/variant testing and multiplex respiratory panels run at a CLIA lab.
